An elevated CHA2DS2-VASc score was associated with an 86% higher odds of no-reflow phenomenon after PCI (OR 1.86; 95% CI 1.51–2.29; p < 0.00001) in 6,557 patients.
Meta-Analysis (n=6,557)
Sí
Is the CHA2DS2-VASc score associated with the occurrence of no-reflow phenomenon in patients undergoing percutaneous coronary intervention?
This systematic review and meta-analysis aims to evaluate the predictive value of the CHA2DS2-VASc score for the no-reflow phenomenon after percutaneous coronary intervention.
Estimación del efecto: OR 1.86 (95% CI 1.51–2.29)
Tasa de eventos absoluta: 16.3% vs 83.7%
valor p: p=<0.00001
Resumo Fundamento O fenômeno de não-refluxo (NR) é uma complicação grave da intervenção coronária percutânea (ICP), associada a desfechos clínicos desfavoráveis. O escore CHA2DS2-VASc, originalmente desenvolvido para avaliar o risco tromboembólico na fibrilação atrial, demonstrou potencial para estar associado a eventos cardiovasculares adversos, mas seu valor preditivo para NR permanece incerto. Objetivo Avaliar a associação entre o escore CHA2DS2-VASc e a ocorrência de NR em pacientes submetidos a ICP por meio de uma revisão sistemática e metanálise. Métodos Foi realizada ...
Özbay et al. (Thu,) conducted a meta-analysis in Patients undergoing percutaneous coronary intervention (PCI), including those with acute ST-segment elevation myocardial infarction (STEMI), non-ST segment elevation myocardial infarction (NSTEMI), and saphenous vein graft intervention (n=6,557). Elevated CHA2DS2-VASc score vs. Lower CHA2DS2-VASc score was evaluated on Occurrence of no-reflow (NR) phenomenon after PCI (OR 1.86, 95% CI 1.51–2.29, p=<0.00001). An elevated CHA2DS2-VASc score was associated with an 86% higher odds of no-reflow phenomenon after PCI (OR 1.86; 95% CI 1.51–2.29; p < 0.00001) in 6,557 patients.